[CASE] Astra Zeneca: Meeting between doctor and patient
Discover how we helped Astra Zeneca get even closer to the target group. Since 2009, our Moment of Truth method has provided unique insight into how Astra Zenecas products are actually presented and perceived in medical consultation.
Astra Zeneca is a leader in asthma treatment in the Nordic markets. Symbicort and the associated Turbuhaler inhaler are brands recognised by both doctors and patients. Astra Zeneca nonetheless needs to get even closer to the target groups.
Since 2009, Ipsos’ Moment of Truth method has provided unique insight into how Symbicort/Turbuhaler are actually presented and perceived in medical consultation. The results comprised a core component of a larger research project in Denmark, Sweden, Norway and Finland. Astra Zeneca uses the results to develop market strategy and improve patient compliance.
Want to know more?
Contact Asger Mortensen, Head of Ipsos UU
Phone: +45 6167 3737
Email: [email protected]
![[Webinar] Ipsos CX Global Voices 2022](/sites/default/files/styles/related_more_insights/public/ct/event/2022-09/CX-Global-Voices-2022-illustration-opti.jpg?itok=OSuo-maX)